News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deal for Millipore Corporation Starting to Pay Off for Merck KGaA
February 23, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Mass Device --Recently acquired Millipore pumped nearly $900 million in additional revenues into Merck Group KGaA (XETRA:MRK) during the second half of 2010, including a $465 million, fourth-quarter contribution.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Psychedelics
Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout
August 12, 2026
·
4 min read
·
Gabrielle Masson
Legal
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
August 12, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset
August 12, 2026
·
1 min read
·
Tristan Manalac
Earnings
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
August 12, 2026
·
2 min read
·
Tristan Manalac
